2 results
Approved WMOCompleted
The objective of this study is to investigate the effect of docetaxel monotherapy and the combination of docetaxel intercalated erlotinib in patients with relapsed EGFR wild type, ALK negative non squamous cell carcinoma.
Approved WMORecruiting
• To assess which preoperative regimen provides superior event free survival 1 year after randomisation in patients with resectable gastric cancer